NCT03290196View on ClinicalTrials.gov

The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics

PHASE4TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 3, 2015

Primary Completion Date

December 22, 2016

Study Completion Date

April 7, 2022

Conditions
Rotator Cuff Tear
Interventions
DRUG

EXPAREL 1.3 % in 20 ML Injection

EXPAREL single shot dose given as an analgesia for arthroscopic rotator cuff repair surgery.

Trial Locations (1)

32561

Andrews Research & Education Foundation, Gulf Breeze

Sponsors
All Listed Sponsors
collaborator

Pacira Pharmaceuticals, Inc

INDUSTRY

lead

Andrews Research & Education Foundation

OTHER

NCT03290196 - The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics | Biotech Hunter | Biotech Hunter